Cargando…

An Open-Label, Multicenter Observational Study for Patients with Alzheimer's Disease Treated with Memantine in the Clinical Practice

BACKGROUND/AIMS: In this post-marketing observational study, the safety and effectiveness of memantine were evaluated in patients with Alzheimer's disease (AD). METHODS: In a 6-month, observational, open-label study at 202 specialist sites in Greece, the effectiveness of memantine was evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stamouli, S.S., Tzanakaki, M., Giatas, S., Georgiadis, G., Papalexi, E., Parashos, I.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2011
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199890/ https://www.ncbi.nlm.nih.gov/pubmed/22163229 http://dx.doi.org/10.1159/000322882

Ejemplares similares

An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough
por: Abdulqawi, Rayid, et al.
Publicado: (2021)

An open-label trial of memantine in treatment-resistant obsessive-compulsive disorder
por: Bakhla, Ajay Kumar, et al.
Publicado: (2013)

An Open-Label Trial of Memantine for Cognitive Impairment in Patients with Posttraumatic Stress Disorder
por: Ramaswamy, Sriram, et al.
Publicado: (2015)

The efficacy of memantine in the treatment of civilian posttraumatic stress disorder: an open-label trial
por: Hori, Hiroaki, et al.
Publicado: (2021)

Update on the use of memantine in Alzheimer’s disease
por: van Marum, Robert J
Publicado: (2009)

Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia
por: Chow, Tiffany W, et al.
Publicado: (2011)

An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer's Disease
por: Gordon, Marc L., et al.
Publicado: (2012)

Memantine Derivatives as Multitarget Agents in Alzheimer’s Disease
por: Marotta, Giambattista, et al.
Publicado: (2020)

Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension
por: Aman, Michael G., et al.
Publicado: (2017)

The Efficacy of Licensed-Indication Use of Donepezil and Memantine Monotherapies for Treating Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Systematic Review and Meta-Analysis
por: Lockhart, I.A., et al.
Publicado: (2011)

Memantine: efficacy and safety in mild-to-severe Alzheimer’s disease
por: Tampi, Rajesh R, et al.
Publicado: (2007)

Therapy of addition for Alzheimer's Disease: combination with galantamine and memantine
por: Zarra, Julio, et al.
Publicado: (2010)

Memantine-induced Myoclonus in a Patient with Alzheimer Disease
por: Murgai, Aditya A., et al.
Publicado: (2015)

Memantine prodrug as a new agent for Alzheimer’s Disease
por: Sestito, Simona, et al.
Publicado: (2019)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
por: Thomas, Stuart J, et al.
Publicado: (2009)

Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
por: Parsons, Chris G., et al.
Publicado: (2013)

Memantine Attenuates Alzheimer’s Disease-Like Pathology and Cognitive Impairment
por: Wang, Xiaochuan, et al.
Publicado: (2015)

An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer’s disease
por: Kainuma, Mosaburo, et al.
Publicado: (2022)

Galantamine-memantine combination superior to donepezil-memantine combination in Alzheimer’s disease: critical dissection with an emphasis on kynurenic acid and mismatch negativity
por: Koola, Maju Mathew, et al.
Publicado: (2018)

Combined application of tenuigenin and β-asarone improved the efficacy of memantine in treating moderate-to-severe Alzheimer’s disease
por: Chang, Wenguang, et al.
Publicado: (2018)

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer’s disease in the Netherlands
por: Hoogveldt, Bart, et al.
Publicado: (2011)

Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Matsunaga, Shinji, et al.
Publicado: (2015)

Effect of memantine, an anti-Alzheimer’s drug, on rodent microglial cells in vitro
por: Murakawa-Hirachi, Toru, et al.
Publicado: (2021)

Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years
por: Farlow, Martin R, et al.
Publicado: (2005)

Pharmacodynamics of Memantine: An Update
por: Rammes, G, et al.
Publicado: (2008)

Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
por: Rountree, Susan D, et al.
Publicado: (2009)

Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
por: Farrimond, Lucy E, et al.
Publicado: (2012)

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
por: Sánchez-López, Elena, et al.
Publicado: (2018)

The effects of memantine on behavioral disturbances in patients with Alzheimer’s disease: a meta-analysis
por: Kishi, Taro, et al.
Publicado: (2017)

Memantine treats psychosis and agitation associated with Moderna COVID-19 vaccine
por: Siao, Wen-Huei, et al.
Publicado: (2023)

Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine
por: Schmidt, R, et al.
Publicado: (2008)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
por: Puangthong, Umamon, et al.
Publicado: (2009)

False recognition in a mouse model of Alzheimer’s disease: rescue with sensory restriction and memantine
por: Romberg, Carola, et al.
Publicado: (2012)

Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial)
por: Knapp, Martin, et al.
Publicado: (2016)

Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's disease
por: Belitskaya-Lévy, Ilana, et al.
Publicado: (2018)

PT592. Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-analysis
por: Matsunaga, Shinji, et al.
Publicado: (2016)

Therapeutic efficacy of novel memantine nitrate MN‐08 in animal models of Alzheimer’s disease
por: Wu, Liangmiao, et al.
Publicado: (2021)

Basic information about memantine and its treatment of Alzheimer's disease and other clinical applications
por: Tang, Bin‐Can, et al.
Publicado: (2023)

Effectiveness and safety of generic memantine hydrochloride manufactured in China in the treatment of moderate to severe Alzheimer's disease: a multicenter, double-blind randomized controlled trial
por: Zhu, Minjie, et al.
Publicado: (2013)

The effects of memantine on prepulse inhibition
por: Swerdlow, NR, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_in3q94atj243j7giq31eov3563